On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
On Dec. 1, 2025, the U.S. Food and Drug Administration (FDA) announced the deployment of agentic AI capabilities…
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
On Nov. 28, 2025, the the World Health Organization (WHO) reported that global immunization efforts have led to…
On Nov. 28, 2025, The Food and Drug Administration (FDA) announced the withdrawal of the proposed rule entitled…
On Nov. 28, 2025, China has banned pork imports from Barcelona province after Spain detected its first case…
On Nov. 26, 2025, researchers at Lund University in Sweden have showed through the DNA analysis of old…
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
On Nov. 25, 2025, recent studies published in PNAS have revealed that many mosquito species regularly engage in…
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
On Nov. 24, 2025, a study published in the New England Journal of Medicine show that a test…
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
On Nov. 21, 2025, state health officials from California, Oregon, Hawaii and Washington issued a statement in response…
On Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
On Nov. 19, 2025, the Texas Animal Health Commission (TAHC) received confirmation of equine herpes myeloencephalopathy (EHM), the…
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
On Nov. 19, 2025, researchers announced a Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a…
On Nov. 19, 2025, Precise Bio announced the first patient has been successfully treated with PB-001, the Company’s…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…